🎉 M&A multiples are live!
Check it out!

Benitec Biopharma Valuation Multiples

Discover revenue and EBITDA valuation multiples for Benitec Biopharma and similar public comparables like Galapagos, Pharming, and Benevolent AI.

Benitec Biopharma Overview

About Benitec Biopharma

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.


Founded

2019

HQ

United States of America
Employees

18

Website

benitec.com

Financials

LTM Revenue n/a

LTM EBITDA n/a

EV

$261M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Benitec Biopharma Financials

Benitec Biopharma has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.

In the most recent fiscal year, Benitec Biopharma achieved revenue of n/a and an EBITDA of -$22.1M.

Benitec Biopharma expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Benitec Biopharma valuation multiples based on analyst estimates

Benitec Biopharma P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $0.1M n/a XXX XXX XXX
Gross Profit $0.1M n/a XXX XXX XXX
Gross Margin 85% NaN% XXX XXX XXX
EBITDA -$19.1M -$22.1M XXX XXX XXX
EBITDA Margin -25531% -Infinity% XXX XXX XXX
Net Profit -$18.2M -$19.6M XXX XXX XXX
Net Margin -24277% -Infinity% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Benitec Biopharma Stock Performance

As of April 15, 2025, Benitec Biopharma's stock price is $13.

Benitec Biopharma has current market cap of $339M, and EV of $261M.

See Benitec Biopharma trading valuation data

Benitec Biopharma Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$261M $339M XXX XXX XXX XXX $-1.96

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Benitec Biopharma Valuation Multiples

As of April 15, 2025, Benitec Biopharma has market cap of $339M and EV of $261M.

Benitec Biopharma's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate Benitec Biopharma's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Benitec Biopharma and 10K+ public comps

Benitec Biopharma Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $261M XXX XXX XXX
EV/Revenue n/a XXX XXX XXX
EV/EBITDA n/a XXX XXX XXX
P/E -13.6x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF n/a XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Benitec Biopharma Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Benitec Biopharma Valuation Multiples

Benitec Biopharma's NTM/LTM revenue growth is n/a

Benitec Biopharma's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged $1.2M for the same period.

Over next 12 months, Benitec Biopharma's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Benitec Biopharma's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Benitec Biopharma and other 10K+ public comps

Benitec Biopharma Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth -100% XXX XXX XXX XXX
EBITDA Margin n/a XXX XXX XXX XXX
EBITDA Growth 16% XXX XXX XXX XXX
Rule of 40 (SaaS-only) n/a XXX XXX XXX XXX
Revenue per Employee n/a XXX XXX XXX XXX
Opex per Employee $1.2M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue n/a XXX XXX XXX XXX
Opex to Revenue n/a XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Benitec Biopharma Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics and Genomics & Personalized Medicine comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Benitec Biopharma M&A and Investment Activity

Benitec Biopharma acquired  XXX companies to date.

Last acquisition by Benitec Biopharma was  XXXXXXXX, XXXXX XXXXX XXXXXX . Benitec Biopharma acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Benitec Biopharma

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Benitec Biopharma

When was Benitec Biopharma founded? Benitec Biopharma was founded in 2019.
Where is Benitec Biopharma headquartered? Benitec Biopharma is headquartered in United States of America.
How many employees does Benitec Biopharma have? As of today, Benitec Biopharma has 18 employees.
Who is the CEO of Benitec Biopharma? Benitec Biopharma's CEO is Dr. Jerel A. Banks, PhD.
Is Benitec Biopharma publicy listed? Yes, Benitec Biopharma is a public company listed on NAS.
What is the stock symbol of Benitec Biopharma? Benitec Biopharma trades under BNTC ticker.
When did Benitec Biopharma go public? Benitec Biopharma went public in 2012.
Who are competitors of Benitec Biopharma? Similar companies to Benitec Biopharma include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of Benitec Biopharma? Benitec Biopharma's current market cap is $339M
Is Benitec Biopharma profitable? Yes, Benitec Biopharma is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.